These stocks carry a Buy rating from MOFSL analysts, rank highest in our Quant model, balancing value, quality, momentum, and earnings surprise
Quant Small Cap Fund added five new stocks to its portfolio in July 2025, signaling fresh investment bets. Here's what investors need to know about these picks.
Be mindful that these funds do not have a track record, and changing market conditions can render a model obsolete
Sebi aims to stay proactive as firms expand in India
Stocks to Buy: Motilal Oswal recommends quant strategy for July 2025; here are 5 best tactical bets within the MOFSL universe with a Buy rating.
There may not be any major changes in direct taxation, given that simplification has already been carried out in recent years
Quant funds adopt a systematic, rules-based approach to stock selection and portfolio management. They don't rely on fund managers to make investment decisions
According to the fund house, the model will identify stocks as momentum, value, quality, or growth based on data
However, the fund house has not revealed the name. The new CEO will likely take charge by April 2025, according to the company
The fund house, which manages over Rs 1 trillion worth of assets, had the highest exposure to these stocks among the larger fund houses
In October, the equity market witnessed a sharp fall amid record selling of close to Rs 1 trillion by foreign portfolio investors (FPIs)
The algorithm evaluates more than 300 factors and thousands of data points to detect patterns that could predict price movements in securities
Quant Mutual Fund (MF) on Friday announced that its assets under management (AUM) has crossed the Rs 1 trillion mark
Quant MF has managed to dominate the equity scheme performance charts in recent years, with its high-conviction bets working out well
Private equity firm True North's arm Threpsi Care LLP on Tuesday divested a 2.6 per cent stake in Zydus Wellness for Rs 374 crore through an open market transaction, while Quant Mutual Fund picked up the stake in the consumer wellness company. According to the block deal data available on the National Stock Exchange (NSE), Threpsi Care LLP sold 17 lakh shares, amounting to a 2.67 per cent stake in Ahmedabad-based Zydus Wellness. The shares were disposed of at an average price of Rs 2,201.40 apiece, taking the transaction value to Rs 374.24 crore. After the share sale, Mumbai-based True North's stake in Zydus Wellness has reduced to 7.45 per cent from 10.12 per cent. These shares were acquired by Quant Mutual Fund at the same price. Shares of Zydus Wellness fell 0.16 per cent to close at Rs 2,220 per piece on the NSE. In December last year, True North through its arm Threpsi Care LLP divested a 1.23 per cent stake in Zydus Wellness for Rs 127 crore.
Large AMCs to expedite setting up of institutional mechanism
Says previous CFO Harshal Patel had resigned in February
Reliance Industries and Jio Financial Services are among the top holdings in most schemes
The Mumbai-based asset manager, one of the fastest growing mutual funds in India, has seen its assets soar lately to Rs 93,000 crore ($11.1 billion) from Rs 240 crore in 2019.
): If you're already invested in Quant MF, some advisors suggest holding on for now. But this depends on your own risk tolerance.